The pan-cancer analysis based on TCGA, genotype-tissue expression (GTEx), and the Cancer Cell Line Encyclopedia (CCLE) datasets revealed that the low expression of HDAC6 is a potential biomarker of worse prognosis in several cancers, including thymoma [167]. The gene discussed is HDAC6; the disease is cancer.